Literature DB >> 22962684

Autotaxin through lysophosphatidic acid stimulates polarization, motility, and transendothelial migration of naive T cells.

Yafeng Zhang1, Yi-Chun Maria Chen, Matthew F Krummel, Steven D Rosen.   

Abstract

Blood-borne lymphocytes home to lymph nodes by interacting with and crossing high endothelial venules (HEVs). The transendothelial migration (TEM) step is poorly understood. Autotaxin (ATX) is an ectoenzyme that catalyzes the conversion of lysophosphatidylcholine (LPC) to lysophosphatidic acid (LPA), a bioactive lipid and a close relative of sphingosine 1-phosphate. HEVs produce and secrete ATX into the blood. A prior study implicated ATX in the overall homing process, but the step in which it functions and its mechanism of action have not been defined. In this article, we show that HA130, an inhibitor of the enzymatic activity of ATX, slows T cell migration across lymph node HEVs in vivo. Ex vivo, ATX plus LPC or LPA itself induces the polarization of mouse naive T cells and stimulates their motility on an ICAM-1 substratum. Under physiologic shear conditions in a flow chamber, LPA or ATX/LPC strongly enhances TEM of integrin-arrested T cells across an endothelial monolayer. HA130 blunts the TEM-promoting activity of ATX, paralleling its in vivo effects. T cells possess Mn(+2)-activatable receptors for ATX, which are localized at the leading edge of polarized cells. ATX must bind to these receptors to elicit a maximal TEM response, providing a mechanism to focus the action of LPA onto arrested lymphocytes in flowing blood. Our results indicate that LPA produced via ATX facilitates T cell entry into lymph nodes by stimulating TEM, substantiating an additional step in the homing cascade. This entry role for LPA complements the efflux function of sphingosine 1-phosphate.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22962684      PMCID: PMC3509168          DOI: 10.4049/jimmunol.1201604

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

Review 1.  Autotaxin and LPA receptor signaling in cancer.

Authors:  Anna J S Houben; Wouter H Moolenaar
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

2.  CC chemokine receptor 7 contributes to Gi-dependent T cell motility in the lymph node.

Authors:  Takaharu Okada; Jason G Cyster
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

Review 3.  Bringing up the rear: defining the roles of the uropod.

Authors:  Francisco Sánchez-Madrid; Juan M Serrador
Journal:  Nat Rev Mol Cell Biol       Date:  2009-04-17       Impact factor: 94.444

Review 4.  Tipping the gatekeeper: S1P regulation of endothelial barrier function.

Authors:  Hugh Rosen; M Germana Sanna; Stuart M Cahalan; Pedro J Gonzalez-Cabrera
Journal:  Trends Immunol       Date:  2007-02-05       Impact factor: 16.687

Review 5.  Secondary lymphoid organs: responding to genetic and environmental cues in ontogeny and the immune response.

Authors:  Nancy H Ruddle; Eitan M Akirav
Journal:  J Immunol       Date:  2009-08-15       Impact factor: 5.422

6.  Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D.

Authors:  Silvia Jansen; Cristiana Stefan; John W M Creemers; Etienne Waelkens; Aleyde Van Eynde; Willy Stalmans; Mathieu Bollen
Journal:  J Cell Sci       Date:  2005-06-28       Impact factor: 5.285

7.  Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivo.

Authors:  Jose L Tomsig; Ashley H Snyder; Evgeny V Berdyshev; Anastasia Skobeleva; Chifundo Mataya; Viswanathan Natarajan; David N Brindley; Kevin R Lynch
Journal:  Biochem J       Date:  2009-05-01       Impact factor: 3.857

8.  Finding a way out: lymphocyte egress from lymphoid organs.

Authors:  Susan R Schwab; Jason G Cyster
Journal:  Nat Immunol       Date:  2007-12       Impact factor: 25.606

9.  Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration in vitro and causes tumor regression in vivo.

Authors:  Honglu Zhang; Xiaoyu Xu; Joanna Gajewiak; Ryoko Tsukahara; Yuko Fujiwara; Jianxiong Liu; James I Fells; Donna Perygin; Abby L Parrill; Gabor Tigyi; Glenn D Prestwich
Journal:  Cancer Res       Date:  2009-06-09       Impact factor: 12.701

10.  CCR7 ligands stimulate the intranodal motility of T lymphocytes in vivo.

Authors:  Tim Worbs; Thorsten R Mempel; Jasmin Bölter; Ulrich H von Andrian; Reinhold Förster
Journal:  J Exp Med       Date:  2007-02-26       Impact factor: 14.307

View more
  41 in total

Review 1.  How leukocytes cross the vascular endothelium.

Authors:  Dietmar Vestweber
Journal:  Nat Rev Immunol       Date:  2015-10-16       Impact factor: 53.106

2.  Allergic to autotaxin. A new role for lysophospholipase d and lysophosphatidic Acid in asthma?

Authors:  Steve N Georas
Journal:  Am J Respir Crit Care Med       Date:  2013-10-15       Impact factor: 21.405

3.  Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression.

Authors:  Shannon K Oda; Pamela Strauch; Yuko Fujiwara; Amin Al-Shami; Tamas Oravecz; Gabor Tigyi; Roberta Pelanda; Raul M Torres
Journal:  Cancer Immunol Res       Date:  2013-10       Impact factor: 11.151

Review 4.  Lipid phosphate phosphatases and their roles in mammalian physiology and pathology.

Authors:  Xiaoyun Tang; Matthew G K Benesch; David N Brindley
Journal:  J Lipid Res       Date:  2015-03-26       Impact factor: 5.922

Review 5.  Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression.

Authors:  Lorenzo Federico; Kang Jin Jeong; Christopher P Vellano; Gordon B Mills
Journal:  J Lipid Res       Date:  2015-05-14       Impact factor: 5.922

Review 6.  Future prospects in biologic therapy for systemic lupus erythematosus.

Authors:  William Stohl
Journal:  Nat Rev Rheumatol       Date:  2013-09-10       Impact factor: 20.543

Review 7.  The roles of autotaxin/lysophosphatidic acid in immune regulation and asthma.

Authors:  Seung-Jae Kim; Hyung-Geun Moon; Gye Young Park
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-01-29       Impact factor: 4.698

8.  Autotaxin-Lysophosphatidic Acid Axis Blockade Improves Inflammation by Regulating Th17 Cell Differentiation in DSS-Induced Chronic Colitis Mice.

Authors:  Ya-Lan Dong; Xue-Yun Duan; Yu-Jin Liu; Heng Fan; Meng Xu; Qian-Yun Chen; Zhen Nan; Hui Wu; Shuang-Jiao Deng
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

9.  The polybasic insertion in autotaxin α confers specific binding to heparin and cell surface heparan sulfate proteoglycans.

Authors:  Anna J S Houben; Xander M R van Wijk; Laurens A van Meeteren; Leonie van Zeijl; Els M A van de Westerlo; Jens Hausmann; Alexander Fish; Anastassis Perrakis; Toin H van Kuppevelt; Wouter H Moolenaar
Journal:  J Biol Chem       Date:  2012-11-13       Impact factor: 5.157

Review 10.  Autotaxin: structure-function and signaling.

Authors:  Anastassis Perrakis; Wouter H Moolenaar
Journal:  J Lipid Res       Date:  2014-02-18       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.